K. Gmelin

530 total citations
36 papers, 323 citations indexed

About

K. Gmelin is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, K. Gmelin has authored 36 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 25 papers in Hepatology and 7 papers in Infectious Diseases. Recurrent topics in K. Gmelin's work include Hepatitis B Virus Studies (24 papers), Hepatitis C virus research (18 papers) and Hepatitis Viruses Studies and Epidemiology (13 papers). K. Gmelin is often cited by papers focused on Hepatitis B Virus Studies (24 papers), Hepatitis C virus research (18 papers) and Hepatitis Viruses Studies and Epidemiology (13 papers). K. Gmelin collaborates with scholars based in Germany, China and United States. K. Gmelin's co-authors include Lorenz Theilmann, B Kommerell, Eberhard Pfaff, Jochen Salfeld, Heinz Schaller, Mo‐Quen Klinkert, P. Czygan, R. Waldherr, B. Kallinowski and Gerd Otto and has published in prestigious journals such as The Lancet, Hepatology and The Journal of Infectious Diseases.

In The Last Decade

K. Gmelin

34 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Gmelin Germany 11 262 231 51 33 31 36 323
J. H. Hoofnagle United States 11 295 1.1× 275 1.2× 64 1.3× 9 0.3× 54 1.7× 14 414
Blaine Hollinger United States 12 506 1.9× 487 2.1× 56 1.1× 27 0.8× 35 1.1× 17 626
K Ohba Japan 4 397 1.5× 420 1.8× 55 1.1× 24 0.7× 21 0.7× 6 474
Uta Naumann Germany 12 578 2.2× 575 2.5× 70 1.4× 37 1.1× 36 1.2× 32 680
J Watanabe Japan 10 341 1.3× 349 1.5× 22 0.4× 16 0.5× 27 0.9× 13 469
J.A. McDonald United Kingdom 10 356 1.4× 341 1.5× 53 1.0× 6 0.2× 29 0.9× 12 418
Pierre Berthelot France 9 272 1.0× 250 1.1× 60 1.2× 49 1.5× 20 0.6× 10 447
Bharati Sanghvi United States 4 738 2.8× 699 3.0× 95 1.9× 17 0.5× 26 0.8× 6 821
T Chainuvati Thailand 9 200 0.8× 202 0.9× 129 2.5× 19 0.6× 12 0.4× 19 373
AlfredM. Prince United States 8 304 1.2× 241 1.0× 55 1.1× 13 0.4× 49 1.6× 10 453

Countries citing papers authored by K. Gmelin

Since Specialization
Citations

This map shows the geographic impact of K. Gmelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Gmelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Gmelin more than expected).

Fields of papers citing papers by K. Gmelin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Gmelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Gmelin. The network helps show where K. Gmelin may publish in the future.

Co-authorship network of co-authors of K. Gmelin

This figure shows the co-authorship network connecting the top 25 collaborators of K. Gmelin. A scholar is included among the top collaborators of K. Gmelin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Gmelin. K. Gmelin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goeser, Tobias, Hans‐Michael Müller, Christine Solbach, et al.. (1994). Prevalence and serological manifestation of hepatitis C virus infection in patients with hepatitis non-A, non-B: a follow-up study.. PubMed. 23(17). 793–6. 4 indexed citations
2.
Gmelin, K., B. Kallinowski, Tobias Goeser, et al.. (1992). Follow-up of patients with hepatitis non-A, non-B: incidence and persistence of anti-HCV depend on route of transmission. PubMed. 4. 222–226. 1 indexed citations
3.
Kallinowski, B., K. Gmelin, B Kommerell, et al.. (1992). Immunogenicity, reactogenicity and consistency of a new, inactivated hepatitis A vaccine — a randomized multicentre study with three consecutive vaccine lots. Vaccine. 10(8). 500–501. 6 indexed citations
4.
Theilmann, Lorenz, B. Kallinowski, K. Gmelin, et al.. (1992). Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine. Vaccine. 10. S132–S134. 11 indexed citations
5.
Arnold, Jayantha, Thomas Kraus, Gordon Otto, et al.. (1992). Liver transplantation for acute or chronic liver failure by hepatitis non-A, non-B and hepatitis C viral infections: a postoperative follow-up.. PubMed. 30(8). 525–8. 1 indexed citations
6.
Theilmann, Lorenz, et al.. (1991). BILIARY SECRETION OF BILE ACIDS, LIPIDS, AND BILIRUBIN BY THE TRANSPLANTED LIVER. Transplantation. 52(6). 1020–1022. 19 indexed citations
7.
Kallinowski, B., et al.. (1991). Prevalence of Antibodies to Hepatitis C Virus in Hemodialysis Patients. ˜The œNephron journals/Nephron journals. 59(2). 236–238. 14 indexed citations
8.
Otto, G., et al.. (1989). HEPATIC TRANSPLANTATION IN GALACTOSEMIA. Transplantation. 47(5). 902–902. 14 indexed citations
9.
Theilmann, Lorenz, Mo‐Quen Klinkert, K. Gmelin, B Kommerell, & Eberhard Pfaff. (1987). Detection of antibodies against pre-S1 proteins in sera of patients with hepatitis B virus (HBV) infection. Journal of Hepatology. 4(1). 22–28. 17 indexed citations
10.
Theilmann, Lorenz, et al.. (1987). Pre-S1 proteins in sera of patients positive for HBsAg and antibodies to hepatitis delta virus.. PubMed. 34(2). 53–5. 1 indexed citations
11.
Pfaff, Eberhard, Jochen Salfeld, K. Gmelin, Heinz Schaller, & Lorenz Theilmann. (1987). Synthesis of the X-protein of hepatitis B virus in vitro and detection of anti-X antibodies in human sera. Virology. 158(2). 456–460. 37 indexed citations
12.
Roggendorf, Michael, K. Gmelin, G. Zoulek, et al.. (1986). Epidemiological studies on the prevalence of hepatitis delta virus infections in the Federal Republic of Germany. Journal of Hepatology. 2(2). 230–236. 14 indexed citations
13.
Theilmann, Lorenz, Mo‐Quen Klinkert, K. Gmelin, et al.. (1986). Detection of Pre–S1 Proteins in Serum and Liver of Hbsag–Positive Patients: A New Marker for Hepatitis B Virus Infection. Hepatology. 6(2). 186–190. 51 indexed citations
14.
Gmelin, K., et al.. (1983). Non-A, non-B hepatitis in hemodialysis.. PubMed. 54. 483–6. 3 indexed citations
15.
Gmelin, K., et al.. (1982). Hepatitis A and B markers and presumable non-A, non-B hepatitis in a psychiatric institution.. PubMed. 176(1). 15–27. 2 indexed citations
16.
Raedsch, R., A. Stiehl, R Waldherr, et al.. (1982). Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value.. PubMed. 20(12). 738–43. 30 indexed citations
17.
Ferner, Helmut, et al.. (1982). [Psychosomatic differentiation between colitis ulcerosa and ileitis terminalis (Crohn disease)].. PubMed. 27(4). 358–71.
18.
Gmelin, K., et al.. (1976). Das e-Antigen. DMW - Deutsche Medizinische Wochenschrift. 101(43). 1573–1575. 3 indexed citations
19.
Gmelin, K., et al.. (1976). e ANTIGEN: PROGNOSTIC MARKER IN ACUTE VIRAL HEPATITIS B?. The Lancet. 308(7985). 577–577. 12 indexed citations
20.
Gmelin, K., et al.. (1973). [Studies of liver biopsies in thalassaemia major (author's transl)].. PubMed. 57. 251–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026